Overview: Glucose 1H Post 100g TestIntroduction: The Glucose 1H Post 100g Test measures glucose 1 hour after a 100g load to diagnose gestational diabetes, causing fatigue or thirst. Aligned with 2023 ACOG guidelines, it uses spectrophotometry for high sensitivity, aiding in pregnancy screening. This test is critical for guiding diagnosis, management, and improving outcomes in biochemistry for pregnant patients. It is part of the oral glucose tolerance test (OGTT) to assess glucose metabolism during pregnancy.
Other Names: Glucose 1H 100g Assay, Gestational OGTT 1H Test.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic accuracy.
Historical Milestone: Glucose tolerance testing began in the 1960s with diabetes research. The 100g OGTT for gestational diabetes was standardized in the 1980s, with spectrophotometry refinements in the 1990s.
Purpose: Diagnoses gestational diabetes, guides management, and monitors glucose levels in pregnant patients with fatigue, thirst, or excessive urination.
Test Parameters: 1. Glucose (1.0 H Post 100g)
Pretest Condition: Fasting for 10-12 hours required. Collect plasma or serum 1 hour after 100g glucose load. Report symptoms like fatigue, thirst, or polyuria, and list medications.
Specimen: 2-4 mL plasma (NaF) or 2-5 mL serum (SST). Centrifuge within 1 hour. Transport in a biohazard bag within 24 hours.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: Not frozen
Medical History: Document fatigue, thirst, polyuria, or history of gestational diabetes. Include pregnancy stage, current medications, and family history of diabetes.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for diabetes management or monitoring.
Procedural Considerations: Uses spectrophotometry to measure glucose levels 1 hour post-100g load. Results are available in 1-2 days, enabling rapid clinical decisions. Performed in laboratories, typically as part of a multi-point OGTT.
Factors Affecting Result Accuracy: Non-fasting, improper timing, hemolysis, or medications (e.g., corticosteroids) can affect results. Patient stress may alter glucose levels.
Clinical Significance: Elevated glucose levels suggest gestational diabetes, prompting dietary or insulin management. Normal levels may require further testing to confirm.
Specialist Consultation: Consult an obstetrician or endocrinologist for result interpretation and pregnancy management.
Additional Supporting Tests: 3-hour OGTT, HbA1c, fasting glucose, or ultrasound to confirm gestational diabetes and assess fetal health.
Test Limitations: Single time-point results may miss dynamic glucose changes. Results require clinical correlation and multi-point testing for accuracy.
References: ACOG Gestational Diabetes Guidelines, 2023; Obstetrics & Gynecology, Metzger BE, 2022.
